文献速递乳房整形与再造显微修复重建

肋间动脉穿支皮瓣:以改良肿瘤整形方法扩展保乳治疗

The Intercostal Artery Perforator Flap: Expanding Breast-Conserving Therapy With a Modified Oncoplastic Approach.
PubMed 文献 · Ann Plast Surg · 2023-01-18

单中心研究纳入27例肋间动脉穿支皮瓣(ICAP)重建部分乳房切除缺损的患者,与27例乳房切除后组织扩张器(TE)重建患者比较。ICAP组整形特异性手术时间显著更长(P<0.01),但总手术时间无差异(P>0.05);TE组住院时间显著更长、主要术后并发症显著更常见(P<0.01,P>0.05)。ICAP组需门诊阿片类药物续方的患者为1例(4%),TE组为7例(26%)(P=0.02)。作者认为ICAP皮瓣可有效扩展保乳治疗适应证,且该技术易于采用、复杂度有限。

要点

  • ICAP皮瓣可重建乳房皮肤、乳头乳晕或大体积缺损,扩展保乳治疗适应证。
  • TE组住院时间显著更长、主要术后并发症显著更常见(P<0.01,P>0.05)。
  • ICAP组门诊阿片类药物续方1例(4%)vs TE组7例(26%)(P=0.02)。

核心结论

  • 作者认为,采用ICAP皮瓣行肿块切除重建可有效扩展保乳治疗在乳房皮肤、乳头乳晕或大体积缺损切除中的适应证。
  • 作者认为该技术易于采用且复杂度有限,增强保乳手术可能较乳房切除重建改善结局;ICAP患者可能需要更少阿片类药物、更短住院时间和更低手术负担。

研究设计与样本

  • 单中心研究,纳入所有在该机构接受ICAP皮瓣重建部分乳房切除缺损的患者。
  • 记录人口学数据、术中数据和术后结局,并将ICAP皮瓣结局与乳房切除后标准异体材料重建进行比较。
  • 27例患者接受ICAP皮瓣,对照为27例单侧组织扩张器(TE)患者。

主要发现

  • 6例包含乳头乳晕重建,6例包含皮肤表面重塑;平均缺损大小为217.7(30.3-557.9)cm³。
  • ICAP组整形特异性手术时间显著更长(P<0.01),总手术时间无差异(P>0.05)。
  • TE组住院时间显著更长、主要术后并发症显著更常见(P<0.01,P>0.05)。
  • TE组7例需门诊阿片类药物续方(26%)vs ICAP组1例(4%)(P=0.02)。
  • ICAP组1例需额外手术;患者报告对美学结局满意;ICAP组平均随访7个月。

临床怎么用

  • 作者认为,ICAP皮瓣可用于乳房皮肤、乳头乳晕或大体积缺损切除后的肿块切除重建,以扩展保乳治疗适应证。
  • 作者认为该技术易于采用且复杂度有限;ICAP患者可能需要更少阿片类药物、更短住院时间和更低手术负担。

局限性

  • ICAP组平均随访7个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Historically, breast-conserving surgery may not be pursued when the oncologic deformity is too significant and/or not tolerant of radiotherapy. Reconstruction using recruitment of upper abdominal wall tissue based on the intercostal artery perforating vessels can expand breast conservation therapy indications for cases that would otherwise require mastectomy. This report aims to describe the expanded use of the intercostal artery perforator (ICAP) as well as detail its ease of adoption. METHODS: All patients who underwent ICAP flaps for reconstruction of partial mastectomy defects at a single institution were included. Demographic data, intraoperative data, and postoperative outcomes were recorded. Intercostal artery perforator flap outcomes are compared with standard alloplastic reconstruction after mastectomy. RESULTS: Twenty-seven patients received ICAP flaps compared with 27 unilateral tissue expanders (TE). Six cases included nipple-areolar reconstruction, and 6 included skin resurfacing. The average defect size was 217.7 (30.3-557.9) cm 3 . Plastic-specific operative time was significantly longer in the ICAP cohort ( P < 0.01) with no difference in total operative time ( P > 0.05). Length of stay was significantly longer, and major postoperative complications were significantly more common in TE patients ( P < 0.01, P > 0.05). Seven TE patients required outpatient opiate refills (26%) versus 1 ICAP patient (4%) ( P = 0.02). One ICAP patient required additional surgery. Patients reported satisfaction with aesthetic outcomes. Average follow-up in the ICAP cohort was 7 months. CONCLUSIONS: Lumpectomy reconstruction using ICAP flaps can effectively expand breast conservation therapy indications in resection of breast skin, nipple-areola, or large volume defects. This technique is adoptable and of limited complexity. Enhancing breast-conserving surgery may improve outcomes compared with mastectomy reconstruction. Intercostal artery perforator patients may require fewer opioids, shorter hospital stays, and lower operative burden.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Leach GA, Clark RC, Tong S, et al. The Intercostal Artery Perforator Flap: Expanding Breast-Conserving Therapy With a Modified Oncoplastic Approach. Ann Plast Surg. 2023. PMID: 36752509. doi:10.1097/SAP.0000000000003405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。